{"nct_id":"NCT00321711","title":"Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents","status":"COMPLETED","status_verified_date":"2018-09","start_date":"2006-10-01","start_date_type":"ACTUAL","primary_completion_date":"2009-10-19","primary_completion_date_type":"ACTUAL","completion_date":"2009-10-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}